253 related articles for article (PubMed ID: 19420197)
21. A Phase II Clinical Trial of an Aromatase Inhibitor for Postmenopausal Women with Lymphangioleiomyomatosis.
Lu C; Lee HS; Pappas GP; Dilling DF; Burger CD; Shifren A; Veeraraghavan S; Chapman JT; Parambil J; Ruoss SJ; Young LR; Hammes SR; Kopras EJ; Roads T; Krischer JP; McCormack FX;
Ann Am Thorac Soc; 2017 Jun; 14(6):919-928. PubMed ID: 28570161
[TBL] [Abstract][Full Text] [Related]
22. Long-term efficacy and safety of sirolimus therapy in patients with lymphangioleiomyomatosis.
Hu S; Wu X; Xu W; Tian X; Yang Y; Wang ST; Liu S; Xu X; Xu KF
Orphanet J Rare Dis; 2019 Aug; 14(1):206. PubMed ID: 31429781
[TBL] [Abstract][Full Text] [Related]
23. Role of serum vascular endothelial growth factor D in discrimination of patients with polycystic lung diseases.
Radzikowska E; Jaguś P; Skoczylas A; Sobiecka M; Chorostowska-Wynimko J; Wiatr E; Kuś J; Roszkowski-Śliż K
Pol Arch Med Wewn; 2013; 123(10):533-8. PubMed ID: 24060688
[TBL] [Abstract][Full Text] [Related]
24. Isolation and characterisation of lymphatic endothelial cells from lung tissues affected by lymphangioleiomyomatosis.
Nishino K; Yoshimatsu Y; Muramatsu T; Sekimoto Y; Mitani K; Kobayashi E; Okamoto S; Ebana H; Okada Y; Kurihara M; Suzuki K; Inazawa J; Takahashi K; Watabe T; Seyama K
Sci Rep; 2021 Apr; 11(1):8406. PubMed ID: 33863980
[TBL] [Abstract][Full Text] [Related]
25. Serum VEGF-D a concentration as a biomarker of lymphangioleiomyomatosis severity and treatment response: a prospective analysis of the Multicenter International Lymphangioleiomyomatosis Efficacy of Sirolimus (MILES) trial.
Young L; Lee HS; Inoue Y; Moss J; Singer LG; Strange C; Nakata K; Barker AF; Chapman JT; Brantly ML; Stocks JM; Brown KK; Lynch JP; Goldberg HJ; Downey GP; Swigris JJ; Taveira-DaSilva AM; Krischer JP; Trapnell BC; McCormack FX;
Lancet Respir Med; 2013 Aug; 1(6):445-52. PubMed ID: 24159565
[TBL] [Abstract][Full Text] [Related]
26. Extrapulmonary lymphangioleiomyomatosis presented as the asymptomatic retroperitoneal tumours--two cases report.
Słodkowska J; Patera J; Breborowicz J; Jarzemska A; Korzeniewska-Kosela M; Siemiatkowska K; Radzikowska E; Przybylski G; Kozłowski W
Pol J Pathol; 2006; 57(4):205-7. PubMed ID: 17285764
[TBL] [Abstract][Full Text] [Related]
27. Sirolimus Therapy for Patients With Lymphangioleiomyomatosis Leads to Loss of Chylous Ascites and Circulating LAM Cells.
Harari S; Elia D; Torre O; Bulgheroni E; Provasi E; Moss J
Chest; 2016 Aug; 150(2):e29-32. PubMed ID: 27502989
[TBL] [Abstract][Full Text] [Related]
28. Vascular endothelial growth factors C and D induces proliferation of lymphangioleiomyomatosis cells through autocrine crosstalk with endothelium.
Issaka RB; Oommen S; Gupta SK; Liu G; Myers JL; Ryu JH; Vlahakis NE
Am J Pathol; 2009 Oct; 175(4):1410-20. PubMed ID: 19717640
[TBL] [Abstract][Full Text] [Related]
29. Clinical features, epidemiology, and therapy of lymphangioleiomyomatosis.
Taveira-DaSilva AM; Moss J
Clin Epidemiol; 2015; 7():249-57. PubMed ID: 25897262
[TBL] [Abstract][Full Text] [Related]
30. Molecular and genetic analysis of disseminated neoplastic cells in lymphangioleiomyomatosis.
Crooks DM; Pacheco-Rodriguez G; DeCastro RM; McCoy JP; Wang JA; Kumaki F; Darling T; Moss J
Proc Natl Acad Sci U S A; 2004 Dec; 101(50):17462-7. PubMed ID: 15583138
[TBL] [Abstract][Full Text] [Related]
31. Lymphangioleiomyomatosis: Searching for potential biomarkers.
Revilla-López E; Ruiz de Miguel V; López-Meseguer M; Berastegui C; Boada-Pérez M; Mendoza-Valderrey A; Arjona-Peris M; Zapata-Ortega M; Monforte V; Bravo C; Roman A; Gómez-Ollés S; Sáez-Giménez B
Front Med (Lausanne); 2023; 10():1079317. PubMed ID: 36817769
[TBL] [Abstract][Full Text] [Related]
32. Immunohistological features related to functional impairment in lymphangioleiomyomatosis.
Nascimento ECTD; Baldi BG; Mariani AW; Annoni R; Kairalla RA; Pimenta SP; da Silva LFF; Carvalho CRR; Dolhnikoff M
Respir Res; 2018 May; 19(1):83. PubMed ID: 29739412
[TBL] [Abstract][Full Text] [Related]
33. Changes in lung function and chylous effusions in patients with lymphangioleiomyomatosis treated with sirolimus.
Taveira-DaSilva AM; Hathaway O; Stylianou M; Moss J
Ann Intern Med; 2011 Jun; 154(12):797-805, W-292-3. PubMed ID: 21690594
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of the extent of pulmonary cysts and their association with functional variables and serum markers in lymphangioleiomyomatosis (LAM).
Baldi BG; Araujo MS; Freitas CS; da Silva Teles GB; Kairalla RA; Dias OM; Pereira DA; Pimenta SP; Carvalho CR
Lung; 2014 Dec; 192(6):967-74. PubMed ID: 25201087
[TBL] [Abstract][Full Text] [Related]
35. Functional improvements in patients with lymphangioleiomyomatosis after sirolimus: an observational study.
Zhan Y; Shen L; Xu W; Wu X; Zhang W; Wang J; Li X; Yang Y; Tian X; Xu KF
Orphanet J Rare Dis; 2018 Feb; 13(1):34. PubMed ID: 29458386
[TBL] [Abstract][Full Text] [Related]
36. Lymphangioleiomyomatosis: differential diagnosis and optimal management.
Xu KF; Lo BH
Ther Clin Risk Manag; 2014; 10():691-700. PubMed ID: 25187723
[TBL] [Abstract][Full Text] [Related]
37.
Hou G; Jiang Y; Xu W; Zhu Z; Huo L; Chen X; Li F; Xu KF; Cheng W
Orphanet J Rare Dis; 2021 Jun; 16(1):279. PubMed ID: 34134735
[TBL] [Abstract][Full Text] [Related]
38. Sirolimus and Autophagy Inhibition in Lymphangioleiomyomatosis: Results of a Phase I Clinical Trial.
El-Chemaly S; Taveira-Dasilva A; Goldberg HJ; Peters E; Haughey M; Bienfang D; Jones AM; Julien-Williams P; Cui Y; Villalba JA; Bagwe S; Maurer R; Rosas IO; Moss J; Henske EP
Chest; 2017 Jun; 151(6):1302-1310. PubMed ID: 28192114
[TBL] [Abstract][Full Text] [Related]
39. Effect of a gonadotrophin-releasing hormone analogue on lung function in lymphangioleiomyomatosis.
Harari S; Cassandro R; Chiodini I; Taveira-DaSilva AM; Moss J
Chest; 2008 Feb; 133(2):448-54. PubMed ID: 18071009
[TBL] [Abstract][Full Text] [Related]
40. Pulmonary lymphangioleiomyomatosis. A study of 69 patients. Groupe d'Etudes et de Recherche sur les Maladies "Orphelines" Pulmonaires (GERM"O"P).
Urban T; Lazor R; Lacronique J; Murris M; Labrune S; Valeyre D; Cordier JF
Medicine (Baltimore); 1999 Sep; 78(5):321-37. PubMed ID: 10499073
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
